---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-025926"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2026-04-20T23:59:59+00:00"
generated_at: "2026-05-15T05:20:04.320975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics receives $53.9M from exercise of Series A warrants; issues 33.6M common shares

## Summary
- Series A warrants from Oct 2025 private placement expired on April 17, 2026; 38,481,325 underlying shares.
- Investors exercised 33,597,860 shares at $1.40 each and 4,883,464 pre-funded warrants at $1.399 each.
- Gross proceeds of approximately $53.9 million to the company.

## SEC filing metadata
- accession: 0001628280-26-025926
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2026-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/0001628280-26-025926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/ovid-20260420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-025926
- JSON: https://secwatch.observer/filing/0001628280-26-025926.json
- Plain text: https://secwatch.observer/filing/0001628280-26-025926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.